sh-Polypeptide-5

Functions
Anti-aging
Firming
Smoothing
Antiscarring agent
CAS Number(s)
182212-66-4
FDA UNII
2Q1GS25JWN
INCI name
sh-Polypeptide-5
Origin
Biotechnological

sh-Polypeptide-5 is a synthetic recombinant peptide, an analog of human TGFβ3 (Transforming Growth Factor β3). It regulates the proliferation, growth, and differentiation of skin cells as a potent, multifunctional cytokine, and helps keep the skin young by converting old cells into new ones.

Naturally, TGFβ3 is a signaling cytokine secreted in response to bleeding or skin damage. sh-Polypeptide-5 promotes regenerative processes, accelerates wound healing, and prevents scar formation. It boosts the production of extracellular matrix (ECM) proteins, including collagens I, III, IV, and V, elastin, fibronectin, and thrombospondin.

Improving the organization of structural proteins (collagen and elastin), sh-Polypeptide-5 enhances dermal cell adhesion to the matrix, leaving a significant smoothing, firming, and anti-aging effect. In addition, it transduces signals to other cytokines involved in skin repair.

sh-Polypeptide-5 works cooperatively with other cytokines to restore injuries and environmental damage. It is a potent and safe ingredient for modern anti-aging applications. Some studies showed that TGFβ3 has protective properties against tumorigenesis. However, any growth factor-mimicking peptide should be used with caution, as GFs are correlated with tumorigenesis or progression.
Synonyms
Recombinant Human Transforming Growth Factor-β3
CG-TGF-β3
Human Oligopeptide-7
rh-Oligopeptide-7
Avotermin
Changed

References

Transforming growth factor-beta3-loaded microtextured membranes for skin regeneration in dermal wounds
Author(s):
, , , ,
PMID:
15293313
DOI:
10.1002/jbm.a.30095
Transforming growth factor beta (TGF-β) isoforms in wound healing and fibrosis
Author(s):
, ,
PMID:
26704519
DOI:
10.1111/wrr.12398
Prevention and reduction of scarring in the skin by Transforming Growth Factor beta 3 (TGFbeta3): from laboratory discovery to clinical pharmaceutical
Author(s):
, , ,
PMID:
18644230
DOI:
10.1163/156856208784909345
Discovery and development of avotermin (recombinant human transforming growth factor beta 3): a new class of prophylactic therapeutic for the improvement of scarring
Author(s):
, , , , , , ,
PMID:
21793965
DOI:
10.1111/j.1524-475X.2011.00711.x
TGF-beta3 and cancer: a review
Author(s):
, , , ,
PMID:
19656717
DOI:
10.1016/j.cytogfr.2009.07.002